News | 30 July 2012
AcelRx Pharmaceuticals (ACRX) is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. AcelRx's lead product candidate, the ARX-01 Sufentanil ...
Click on the link to read the full article at Seeking Alpha
(This link will open in a new window)